AMELIAM CONSULTANCY LIMITED
Company number 13976221 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
AMELIAM CONSULTANCY LIMITED - Analysis Report
Company Number: 13976221
Analysis Date: 2025-07-20 15:30 UTC
Financial Health Assessment: AMELIAM CONSULTANCY LIMITED (as of 31 March 2024)
1. Financial Health Score: D
Explanation:
The company is showing clear symptoms of financial distress with persistent net liabilities, negative working capital, and an erosion of shareholders’ funds. While it remains active and operational, the balance sheet reveals a fragile state that requires urgent attention to avoid worsening health. This grade reflects the company’s inability currently to cover short-term obligations comfortably and the ongoing depletion of equity.
2. Key Vital Signs
| Metric | 2024 Value | Interpretation |
|---|---|---|
| Fixed Assets | £1,740 | Small asset base consistent with service-focused business. |
| Current Assets (Cash only) | £3,313 | All current assets are cash, indicating no accounts receivable or stock—good liquidity but low buffer. |
| Current Liabilities | £7,194 | Short-term debts significantly higher than current assets. |
| Net Current Assets | -£3,881 | Negative working capital — symptoms of liquidity stress; company may struggle to meet short-term obligations. |
| Total Assets Less Current Liabilities | -£2,141 | Overall negative net assets after covering short-term liabilities. |
| Net Assets / Shareholders' Funds | -£2,141 | Negative equity signals accumulated losses or undercapitalisation. |
| Director’s Loan Account | £3,948 | Reliance on director funding to support operations, an indicator of external financing needs. |
3. Diagnosis: What the Numbers Reveal
"Financial Vital Signs" Analysis:
- The company’s working capital deficit (negative net current assets) is a critical symptom indicating that current liabilities exceed current assets by a significant margin (£3,881). This suggests potential challenges in meeting immediate debts without additional funding or asset sales.
- The net liabilities position (negative shareholders’ funds) indicates that accumulated losses exceed the capital invested by shareholders, reflecting ongoing unprofitability or insufficient capital injections since incorporation.
- The director’s loan account balance has nearly quadrupled compared to the previous year (£12,000 advanced in 2024), showing reliance on internal director financing to keep the business afloat, a common sign of cash flow distress.
- The company holds no trade receivables or stock, which is typical for a consultancy or brokerage business, but also means all liquidity comes from cash on hand or funding sources.
- The company is small, with only 2 employees, suggesting a lean operation, but the small asset base and persistent liabilities indicate limited cushion against financial shocks.
- The company is under the SIC code 66220, related to insurance agents and brokers, an industry that can face periodic cash flow variability and needs steady capital management.
Summary:
AMELIAM CONSULTANCY LIMITED exhibits symptoms of financial strain, including liquidity risk and negative equity, which are warning signs akin to a patient with a weak heart struggling to pump sufficient blood. The company's financial "pulse" is faint, requiring intervention to stabilize.
4. Recommendations: Actions to Improve Financial Wellness
Strengthen Liquidity:
- Increase cash reserves through new equity injections or short-term loans from financial institutions or shareholders to cover immediate liabilities and improve working capital.
- Negotiate extended payment terms with creditors to ease short-term cash outflows.
Address Negative Equity:
- Consider a capital reorganisation, such as a shareholder cash injection or debt-to-equity conversion of director loans, to restore positive net assets and improve the company’s balance sheet health.
- Explore cost control measures to reduce losses and build retained earnings over time.
Improve Cash Flow Management:
- Implement rigorous cash flow forecasting and monitoring to anticipate liquidity needs and avoid surprises.
- Accelerate collection of any outstanding receivables (if applicable in future periods) and minimise unnecessary expenditures.
Director Funding and Formalisation:
- Formalise director loan arrangements with clear terms to avoid ambiguity and ensure transparency.
- Explore external funding options to reduce reliance on director advances, which may not be sustainable long-term.
Strategic Business Review:
- Assess the company’s revenue generation model and profitability drivers to identify opportunities for growth or diversification.
- Seek professional advice on restructuring or refinancing options if financial distress worsens.
Medical Analogy Summary
The company resembles a patient with a "weak financial heart" struggling with insufficient "blood flow" (cash) to meet its "vital functions" (liabilities). The "negative equity" is like a depleted energy reserve, signaling that the business operations have been consuming more resources than they generate, leading to a precarious condition. Immediate measures to "stabilize the heartbeat" (liquidity) and "replenish energy stores" (capital) are essential to avoid further deterioration.
Sign in to generate a free AI analysis of this company — no password needed, just an email link.